Sana Biotechnology SANA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $123.51M-6.4% | $131.98M-7.2% | $142.2M-14.0% | $165.3M-15.8% | $196.41M-8.9% | ||
| $44.27M0.0% | $44.3M-10.3% | $49.39M-7.1% | $53.15M-10.3% | $59.26M-7.5% | ||
| $248.3M-0.8% | $250.32M+4.3% | $239.99M-7.1% | $258.23M+21.4% | $212.63M-22.0% | ||
| -$248.3M+0.8% | -$250.32M-4.3% | -$239.99M+7.1% | -$258.23M-21.4% | -$212.63M+22.0% | ||
| $3.81M-1.1% | $3.85M-9.0% | $4.23M-27.2% | $5.8M-31.1% | $8.43M-19.5% | ||
| $2.51M+8.9% | $2.31M+91.0% | $1.21M+1,050% | $105K+102% | -$4.61M+0.7% | ||
| -$241.99M+0.9% | -$244.17M-4.2% | -$234.41M+7.0% | -$252.18M-20.9% | -$208.67M+21.8% | ||
| -$0.93+4.1% | -$0.970.0% | -$0.97+8.5% | -$1.06-20.5% | -$0.88+24.1% | ||
| -$248.3M+0.8% | -$250.32M-4.3% | -$239.99M+7.1% | -$258.23M-21.4% | -$212.63M+22.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Sana Biotechnology profitable?
- Sana Biotechnology is not currently profitable: it reported a net loss of $242.0M over the trailing twelve months.
- What is Sana Biotechnology's earnings per share?
- Sana Biotechnology's diluted EPS over the trailing twelve months is $-0.93.
- Where does Sana Biotechnology's income statement data come from?
- Every line is extracted from Sana Biotechnology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.